Therefore, the outcomes of the present investigation provided clinical evidence that lncRNA‐MEG3 is an unfavorable prognostic factor for diabetes in acute stroke populations and revealed a novel therapeutic pathway for protection against diabetic CIRI by inhibiting lncRNA‐MEG3 through the Anxa2‐Akt regulatory axis. The gene discussed is AKT1; the disease is diabetes mellitus.